Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Pediatr Endocrinol Metab ; 32(9): 935-941, 2019 Sep 25.
Article in English | MEDLINE | ID: mdl-31280235

ABSTRACT

Objectives We aimed to evaluate children with type 1 diabetes (T1D) with early age at onset (EAO) for clinical, immune and metabolic features in order to identify age-related disease phenotypes. Methods Comparative study of two groups of T1D children: EAO (≤5 years) and later age at onset (LAO; >5 years), regarding the presence of other autoimmune (AI) diseases, diabetes ketoacidosis and immunologic profile at onset and metabolic data 1 year after diagnosis. Statistical analysis was performed with significance set for p < 0.05. Results The study included 137 children (EAO = 52, mean age 3.6 ± 1.5 [mean ± standard deviation (SD)] and LAO = 85, mean age 10.4 ± 2.9). EAO was more associated with concomitant AI diseases (p = 0.032). Despite no differences in disease onset, EAO presented with lower C-peptide levels (p = 0.01) and higher absolute lymphocyte number (p < 0.0001), with an inverse correlation between these two variables (p = 0.028). Additionally, the EAO group had a higher frequency of serum detection of three antibodies (Abs) (p = 0.0008), specifically insulin Abs (p = 0.0001). One year after diagnosis, EAO had higher total daily insulin (TDI) dose (p = 0.008), despite similar hemoglobin A1c (HbA1c). Conclusions Our data show an association of EAO T1D with more AI diseases, higher number of Abs, lower initial insulin reservoir and higher insulin requirements 1 year after diagnosis. In this group, immune imbalance seems more evident and disease progression faster, probably reflecting distinct "immune environment" with different ages at disease onset. Further studies in the field of immunogenetics and immune tolerance are required, to improve patient stratification and find novel targets for therapeutic intervention.


Subject(s)
Autoantibodies/blood , Autoimmune Diseases/etiology , Biomarkers/blood , Diabetes Mellitus, Type 1/complications , Diabetic Ketoacidosis/etiology , Insulin/therapeutic use , Adolescent , Age of Onset , Autoantibodies/immunology , Autoimmune Diseases/blood , Autoimmune Diseases/diagnosis , Blood Glucose/analysis , C-Peptide/blood , Child , Child, Preschool , Diabetes Mellitus, Type 1/drug therapy , Diabetic Ketoacidosis/blood , Diabetic Ketoacidosis/diagnosis , Female , Follow-Up Studies , Glycated Hemoglobin/analysis , Humans , Hypoglycemic Agents/therapeutic use , Infant , Infant, Newborn , Male , Phenotype , Prognosis , Retrospective Studies
3.
BMJ Case Rep ; 20162016 Jul 26.
Article in English | MEDLINE | ID: mdl-27460948

ABSTRACT

The urachus is an intra-abdominal fibrous remnant of the allantois. The non-involution of the allantois can result in urachal anomalies. The abnormal appearance of the umbilicus may be a sign of such anomalies. We have observed 3 cases of term neonates with atypical appearance of the umbilical stump, all of which manifested urachal anomalies, as documented by ultrasound scan. These appearances are rarely described in the literature, and seem to regress at around 2 months. Therefore, it is important that healthcare professionals should be aware of the possible implications of atypical umbilical stumps, evaluate each case accordingly and, if an urachal anomaly is diagnosed, refer the patient to a paediatric surgery centre, as such malformations carry an underlying risk of infection or malignancy.


Subject(s)
Ultrasonography, Prenatal/methods , Umbilicus/abnormalities , Umbilicus/diagnostic imaging , Urachus/abnormalities , Urachus/diagnostic imaging , Diagnosis, Differential , Female , Humans , Infant, Newborn , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...